1. Biousse V, Newman NJ. Neuro-ophthalmology of mitochondrial diseases. Semin Neurol, 2001, 21(3): 275-291 2. Biousse V, Newman NJ. Neuro-ophthalmology of mitochondrial diseases. Curr Opin Neurol, 2003, 16(1): 35-43 3. Wallace DC. Mitochondrial diseases in man and mouse. Science, 1999, 283(5407): 1482-1488 4. Sharer JD. The adenine nucleotide translocase type 1(ANT1): a new factor in mitochondrial disease. IUBMB Life, 2005, 57(9): 607-614 5. Kiechl S, Horvath R, Luoma P, et al. Two families with autosomal dominant progressive external ophthalmoplegia. J Neurol Neurosurg Psychiatry, 2004, 75(8): 1125-1128 6. Hudson G, Schaefer AM, Taylor RW, et al. Mutation of the linker region of the polymerase gamma-1(POLG1)gene associated with progressive externalophthalmoplegia and Parkinsonism. Arch Neurol, 2007, 64(4): 553-557 7. Invernizzi F, Varanese S, Thomas A, et al. Two novel POLG1 mutations in a patient with progressive external ophthalmoplegia,levodopa-responsive pseudoorthostatic tremor and parkinsonism. Neuromuscul Disord, 2008, 18(6): 460-464 8. Benatar M. A systematic review of diagnostic studies in myasthenia gravis. Neuromuscul Disord, 2006, 16(7): 459-467 9. Luchanok U, Kaminski HJ. Ocular myasthenia:diagnostic and treatment recommendations and the evidence base. Curr Opin Neurol, 2008, 21(1): 8-15
……